ID   T47D-Y
AC   CVCL_1H30
DR   cancercelllines; CVCL_1H30
DR   TOKU-E; 3661
DR   Wikidata; Q54971568
RX   PubMed=8033109;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 13
//
RX   PubMed=8033109;
RA   Sartorius C.A., Groshong S.D., Miller L.A., Powell R.L., Tung L.,
RA   Takimoto G.S., Horwitz K.B.;
RT   "New T47D breast cancer cell lines for the independent study of
RT   progesterone B- and A-receptors: only antiprogestin-occupied
RT   B-receptors are switched to transcriptional agonists by cAMP.";
RL   Cancer Res. 54:3868-3877(1994).
//